These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 23562132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
    Wild PS, Schnabel RB, Lubos E, Zeller T, Sinning CR, Keller T, Tzikas S, Lackner KJ, Peetz D, Rupprecht HJ, Bickel C, Morgenthaler NG, Papassotiriou J, Tiret L, Münzel T, Blankenberg S.
    Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.
    J Am Coll Cardiol; 2007 Apr 10; 49(14):1525-32. PubMed ID: 17418290
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.
    Brouwers FP, de Boer RA, van der Harst P, Struck J, de Jong PE, de Zeeuw D, Gans RO, Gansevoort RT, Hillege HL, van Gilst WH, Bakker SJ.
    Heart; 2012 Sep 10; 98(18):1348-53. PubMed ID: 22821276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P.
    Thromb Res; 2013 Nov 10; 132(5):506-10. PubMed ID: 24060192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Funke-Kaiser A, Havulinna AS, Zeller T, Appelbaum S, Jousilahti P, Vartiainen E, Blankenberg S, Sydow K, Salomaa V.
    Ann Med; 2014 May 10; 46(3):155-62. PubMed ID: 24506434
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
    Kaiser R, Abdul-Khaliq H, Wilkens H, Herrmann E, Raedle-Hurst TM.
    Eur J Heart Fail; 2014 Oct 10; 16(10):1082-8. PubMed ID: 25201135
    [Abstract] [Full Text] [Related]

  • 18. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
    Landman GW, van Dijk PR, Drion I, van Hateren KJ, Struck J, Groenier KH, Gans RO, Bilo HJ, Bakker SJ, Kleefstra N.
    Diabetes Care; 2014 Oct 10; 37(3):839-45. PubMed ID: 24170764
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation.
    Parwani AS, von Haehling S, Kolodziejski AI, Huemer M, Wutzler A, Attanasio P, Stojakovic T, Scharnagl H, Haverkamp W, Boldt LH.
    Int J Cardiol; 2015 Feb 01; 180():129-33. PubMed ID: 25438233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.